-
Mashup Score: 4
Las investigaciones realizadas en estas unidades estarán destinadas a evaluar la eficacia y seguridad de nuevos tratamientos oncológicos, mejorar los…
Source: www.plantadoce.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 17Visibilizar el cáncer de pulmón a través de la ascensión a montañas: "Cuando me diagnosticaron jamás pensé que podría hacer un dosmil" - 1 month(s) ago
Asciendo dando pequeños pasos, apoyada en los bastones de trekking. Mi corazón se acelera. Un vistazo al pulsómetro para certificarlo, aunque no haría falta: noto los latidos…
Source: www.elmundo.esCategories: General Medicine News, Oncologists2Tweet-
Visibilizar el cáncer de pulmón a través de la ascensión a montañas: "Cuando me diagnosticaron jamás pensé que podría hacer un dosmil" | Madrid https://t.co/Jg9UYkUAGE
-
-
Mashup Score: 16“Dual-Target” cell therapy appears to shrink brain tumors - 2 month(s) ago
Early Phase I clinical trial results from six patients with recurrent glioblastoma show that a “dual-target” CAR T cell therapy approach may be a promising step towards developing cell therapies for solid tumors.
Source: www.pennmedicine.orgCategories: General Medicine News, Oncologists2Tweet-
Muy preliminar, muy impresionante. https://t.co/bnamWWhO3t
-
-
Mashup Score: 0Lo Pulmó 23 - Ricky Rubio Foundation - 7 month(s) ago
El 27 de octubre próximo en el auditorio Cappont de la Universidad de Lleida, se llenará de conocimiento y esperanza con la segunda edición de “Lo Pulmó”, el congreso dedicado exclusivamente a la investigación, diagnóstico, tratamiento y cuidado de las personas afectadas por el cáncer de pulmón. Este evento, respaldado por The Ricky Rubio Foundation y el UOMI Cancer Center, reunirá a expertos y científicos destacados en el campo del cáncer de pulmón para discutir los avances más recientes en esta área.
Source: therickyrubiofoundation.orgCategories: Latest Headlines, Oncologists2Tweet-
Inscríbete gratuitamente en "Lo Pulmó 23", la reunión de actualización en cáncer de pulmón que celebramos el 27 de octubre en Lleida. Este año trataremos sobre el diagnóstico y manejo del cáncer de pulmón en etapas iniciales. ¡No te lo pierdas! https://t.co/Smi5ocvWkC
-
-
Mashup Score: 4Please wait whilst we redirect you - 11 month(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists2Tweet-
RT @Al3ssandroRusso: Here’s the free link: https://t.co/hDphG6cM7O
-
-
Mashup Score: 0Fluorescence In Situ Hybridization (FISH) for the Characterization and Monitoring of Primary Cultures from Human Tumors - 1 year(s) ago
Genetic and drug sensitivity assays on primary cultures are not only of basic but also of translational interest and could eventually aid oncologists in the selection of treatments. However, cancer cells need to be identified and differentiated from the non-tumor cells always present in primary cultures. Also, successive passages can change the proportions of these two subpopulations. In this…
Source: MDPICategories: Latest Headlines, Oncologists2Tweet-
Check our recent publication! Fluorescence In Situ Hybridization (FISH) for the Characterization and Monitoring of Primary Cultures from Human Tumors https://t.co/Rr4UB7le59 #mdpijmp via @MDPIOpenAccess #Cancer #FISH #tumorcultures
-
-
Mashup Score: 2Advances in the use of EGFR TKIs in the Treatment of NSCLC - 1 year(s) ago
Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all cases. Over the last decade, there have been significant advances in the treatment of NSCLC, particularly with the use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). EGFR is a key…
Source: FrontiersCategories: Latest Headlines, Oncologists2Tweet-
Open for submissions! 😀👩🔬🧑💻 Advances in the use of EGFR TKIs in the Treatment of NSCLC @FrontOncology https://t.co/3Ei5Y6f3d6
-
-
Mashup Score: 0
BackgroundAlectinib is first-line therapy in patients with stage IV non-small cell lung carcinoma (NSCLC) and an anaplastic lymphoma kinase (ALK) fusion. A shorter median progression-free survival (mPFS) was observed when alectinib minimum plasma concentrations during steady state (Cmin,SS) were below 435 ng/mL. This may suggest that patients should have an alectinib Cmin,SS ≥ 435 ng/mL for a…
Source: FrontiersCategories: Latest Headlines, Oncologists2Tweet-
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC) https://t.co/upV1jYqRkR
-
-
Mashup Score: 2Cancer Stories: The Art of Oncology: Wearing Your Heart Around Your Neck: Fostering Physician-Patient Relationships Through Sports - 1 year(s) ago
Listen to ASCO’s Journal of Clinical Oncology essay, “Wearing Your Heart Around Your Neck: Fostering Physician-Patient Relationships Through Sports” by Dr. Victoria Wytiaz. The essay is followed by an interview with Wytiaz and host Dr. Lidia Schapira. Wytiaz shares how a shared passion for sports can foster improved physician-patient relationships and empathetic care. TRANSCRIPT Narrator: Wearing…
Source: aoopodcast.libsyn.comCategories: Latest Headlines, Oncologists2Tweet-
Recuerdo cuando era residente y uno de mis mentores me reñía por no saber de futbol para poder charlar con los pacientes 😂. Yo les entraba más por lectura, cine, viajes… https://t.co/sicrM1vfOI
-
-
Mashup Score: 0After four years of treatment for stage 4 cancer I just wanted some encouraging words from my oncologist - 1 year(s) ago
My oncologist has one of those little motivational prints hanging on his waiting room wall, with the simple statement: “trust your instincts.” One day, bored with the long purgatory of the waiting room, I tweet this news to the world with the observation: “If I trusted my instincts, I’d run screaming from this place and never come back.”
Source: medicalxpress.comCategories: Latest Headlines, Oncologists2Tweet-
"The current model of cancer care serves no one's best interests, leaving complex patient needs unmet and exacting a cruel toll on clinicians" https://t.co/avZWu32kVl via @medical_xpress
-
If you are interested in clinical trials, ask me about Pratia Sirius! Uomi de @MiClinicas y Pratia se unen para crear Pratia Sirius en Barcelona y Lleida https://t.co/Xngn9Nd3SB via @Planta_Doce #UOMI #PratiaSirius #Clinicaltrials #ensayosclínicos